Literature DB >> 12955292

Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective.

Wayne S Fenton1, Ellen L Stover, Thomas R Insel.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12955292     DOI： 10.1007/s00213-003-1564-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  4 in total

1.  Medicine. What are the right targets for psychopharmacology?

Authors:  Steven E Hyman; Wayne S Fenton
Journal:  Science       Date:  2003-01-17       Impact factor: 47.728

Review 2.  The neuroanatomies of schizophrenia.

Authors:  R W Buchanan; W T Carpenter
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

3.  Neurocognition and community outcome in schizophrenia: long-term predictive validity.

Authors:  Daryl E Fujii; A Michael Wylie
Journal:  Schizophr Res       Date:  2003-02-01       Impact factor: 4.939

4.  The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

Authors:  Michael F Green; Stephen R Marder; Shirley M Glynn; Susan R McGurk; William C Wirshing; Donna A Wirshing; Robert P Liberman; Jim Mintz
Journal:  Biol Psychiatry       Date:  2002-06-15       Impact factor: 13.382
  4 in total
  14 in total

1.  Habituation and prepulse inhibition of acoustic startle in rodents.

Authors:  Bridget Valsamis; Susanne Schmid
Journal:  J Vis Exp       Date:  2011-09-01       Impact factor: 1.355

Review 2.  The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?

Authors:  Mark A Geyer
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

3.  Neurocognitive predictors of work outcome in recent-onset schizophrenia.

Authors:  Keith H Nuechterlein; Kenneth L Subotnik; Michael F Green; Joseph Ventura; Robert F Asarnow; Michael J Gitlin; Cindy M Yee; Denise Gretchen-Doorly; Jim Mintz
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

4.  Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.

Authors:  John G Csernansky; Maureen Martin; Renu Shah; Amy Bertchume; Jenny Colvin; Hongxin Dong
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

5.  Nuclear receptor TLX stimulates hippocampal neurogenesis and enhances learning and memory in a transgenic mouse model.

Authors:  Kiyohito Murai; Qiuhao Qu; GuoQiang Sun; Peng Ye; Wendong Li; Grace Asuelime; Emily Sun; Guochuan E Tsai; Yanhong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-10       Impact factor: 11.205

6.  Pharmacological characterization of social isolation-induced hyperactivity.

Authors:  Katrine Fabricius; Lone Helboe; Anders Fink-Jensen; Gitta Wörtwein; Björn Steiniger-Brach
Journal:  Psychopharmacology (Berl)       Date:  2010-12-31       Impact factor: 4.530

7.  The Role of Cholinergic Midbrain Neurons in Startle and Prepulse Inhibition.

Authors:  Erin Azzopardi; Andrea G Louttit; Cleusa DeOliveira; Steven R Laviolette; Susanne Schmid
Journal:  J Neurosci       Date:  2018-08-31       Impact factor: 6.167

8.  Failure to confirm an association between Epsin 4 and schizophrenia in a Japanese population.

Authors:  Misty Richards; Yoshimi Iijima; Tomoko Shizuno; Yoko Kamegaya; Hiroaki Hori; Mayu Omori; Kunimasa Arima; Osamu Saitoh; Hiroshi Kunugi
Journal:  J Neural Transm (Vienna)       Date:  2008-08-12       Impact factor: 3.575

Review 9.  Developing translational animal models for symptoms of schizophrenia or bipolar mania.

Authors:  M A Geyer
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

10.  Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.

Authors:  Deanna M Barch; Cameron S Carter
Journal:  Schizophr Bull       Date:  2008-05-21       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.